Results 231 to 240 of about 209,971 (329)

CMOEP regimen in the treatment of untreated peripheral T-cell lymphoma: a multicenter, single-arm, phase I study. [PDF]

Front Immunol
Yu J, Sun X, Gao G, Yu L, Wang J, Qiu L, Qian Z, Li W, Zhang H.   +8 more
europepmc   +1 more source

Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Efficacy and safety of ibrutinib 560 mg once daily or placebo combined with bendamustine and rituximab (BR) were assessed in patients with mantle cell lymphoma in a randomized phase 3 study (SHINE). The analysis described explores the ibrutinib population pharmacokinetics (PK) and exposure‐response (E‐R) relationships of selected efficacy and ...
Per Olsson Gisleskog, Belén Valenzuela, Nicoline Treijtel, Sanjay Deshpande, Todd Henninger, Juan José Perez‐Ruixo   +5 more
wiley   +1 more source

Case Report: Flow cytometric differential diagnosis of a peripheral T-cell lymphoma, NOS with complete loss of CD45 and dim expression of CD3. [PDF]

Pathol Oncol Res
Szalóki G, Szepesi Á, Tárkányi I, Márk Á, Kriston C, Hunyadi A, Mózes R, Barna G.   +7 more
europepmc   +1 more source

The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project [PDF]

, 2009
Junji Suzumiya, K Ohshima, Kazuo Tamura, Kennosuke Karube, Naokuni Uike, Kensei Tobinai, Randy D. Gascoyne, Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger   +9 more
openalex   +1 more source

An Up‐to‐Date Review of Traditional Chinese Medicine in the Treatment of Atherosclerosis: Components, Mechanisms, and Therapeutic Potentials

Phytotherapy Research, EarlyView.
Traditional Chinese medicine in atherosclerosis: multi‐target modulation of pathogenesis. ABSTRACT Atherosclerosis is a chronic inflammatory disease and a major global health concern. In recent years, traditional Chinese medicines (TCMs) have demonstrated multi‐target therapeutic potential against atherosclerosis by modulating inflammatory responses ...
Dilaram Nijat, Qingzhe Zhao, Gulhasal Abdurixit, Jianhua He, Haipeng Liu, Jinyao Li   +5 more
wiley   +1 more source

Rare primary gastric peripheral T-cell lymphoma not otherwise specified: A case report. [PDF]

World J Clin Cases
Jang HR, Lee K, Lim KH.
europepmc   +1 more source

Retrospective analysis of non‐anaplastic peripheral T‐cell lymphoma in pediatric patients in Japan [PDF]

, 2009
Ryōji Kobayashi, Kazumi Yamato, Fumiko Tanaka, Yoshifumi Takashima, Hiroko Inada, Akira Kikuchi, Masaaki Kumagai, Shosuke Sunami, Atsuko Nakagawa, Reiji Fukano, Naoto Fujita, Tetsuo Mitsui, Masahito Tsurusawa, Tetsuya Mori   +13 more
openalex   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

Small, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai, Dhwani Rana, Mitali Patel, Neha Bajwa, Rajendra Prasad, Lalitkumar K. Vora   +5 more
wiley   +1 more source

Intermediate-dose TBI/fludarabine conditioning for allogeneic hematopoietic cell transplantation in patients with peripheral T-cell lymphoma. [PDF]

Bone Marrow Transplant
Krämer I, König L, Luft T, Hegenbart U, Schönland S, Eichkorn T, Stadtherr P, Selberg L, Müller-Tidow C, Dreger P.   +9 more
europepmc   +1 more source

The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience

, 2007
José Rodríguez, E. Condé, Antonio Gutiérrez, R. Arranz, Agathe León, J. Marín, Maurizio Bendandi, Carmen Albó, Marı́a Dolores Caballero   +8 more
openalex   +1 more source